Companies: 10,795·Total market cap: $144.5T
Evogene Ltd.

Evogene Ltd.

EVGNNASDAQHealthcare● Active
$0.58
$-0.04(-5.82%)
Market Cap$5023607
P/E Ratio
52W High$2.42
52W Low$0.52
Overview

Evogene Ltd.(EVGN)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · EVGN · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$3.85M$5.58M$2.98M$1.68M$0.93M
Cost of Revenue$4.09M$2.38M$1.49M$0.91M$0.77M
Gross Profit($0.24M)$3.20M$1.49M$0.77M$0.16M
Gross Margin %(computed)-6.25%57.32%50.03%45.73%17.53%
Operating Expenses
R&D Expenses$7.99M$12.51M$16.20M$20.79M$21.13M
G&A Expenses$5.58M$8.75M$7.37M$10.28M$9.34M
Total Operating Expenses$13.79M$22.00M$23.72M$27.71M$31.12M
Operating Income($14.03M)($18.80M)($22.23M)($26.94M)($30.95M)
Operating Margin %(computed)-364.24%-337.17%-745.51%
Interest Income$2.47M$0.96M$1.25M$0.18M$0.29M
Interest Expense$1.89M$0.12M$0.17M$0.24M$0.40M
Income Before Tax($13.50M)($14.81M)($21.95M)($29.75M)($30.43M)
Income Tax Expense$0.00M$0.01M$0.02M$0.09M$0.01M
Net Income($8.48M)($16.48M)($23.88M)($26.64M)($27.79M)
Net Margin %(computed)-220.22%-295.59%-800.77%
Per Share & EBITDA
EPS (Basic)$-1.08$-2.89$-5.23$-6.46$-0.68
Wtd Avg Shares7.87M5.70M4.57M4.12M41.01M
EBITDA($12.20M)($13.36M)($20.53M)($27.01M)($27.88M)
EBITDA Margin %(computed)-316.56%-239.63%-688.53%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Evogene Ltd.

关于Evogene Ltd.(EVGN)损益表

Evogene Ltd.(EVGN)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,EVGN实现营收$0.00B,毛利润($0.00B)(毛利率-6.25%),净利润($0.01B)(净利率-220.22%)。

常见问题

EVGN · 4 问

Evogene Ltd.(EVGN)2025财年营收为$0.00B,同比down30.9%。

EVGN revenueEVGN salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09